방법 비교

	삶의 만족도 척도 (SWLS)	일반건강설문-12 (GHQ-12)	병원 불안 및 우울 척도 (HADS)
분야	임상심리학	임상심리학	임상심리학
계열	Process / pipeline	Process / pipeline	Process / pipeline
기원 연도	1985	1992	1983
창시자	Ed Diener, Richard A. Emmons, Richard J. Larsen, and Sharon Griffin	David P. Goldberg	Andrew S. Zigmond and Richard P. Snaith
유형	Global life satisfaction self-report	Psychiatric symptom screening	Anxiety and depression screening in medical populations
원전	Diener, E., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985). The Satisfaction with Life Scale. Journal of Personality Assessment, 49(1), 71-75.	Goldberg, D. P. (1972). The detection of psychiatric illness by questionnaire. Oxford University Press.	Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67(6), 361-370.
별칭	SWLS	GHQ-12, GHQ	HADS, HADS-A, HADS-D
관련	5	5	4
요약	The Satisfaction with Life Scale (SWLS) is a brief, five-item self-report measure of global life satisfaction developed by Diener, Emmons, Larsen, and Griffin in 1985. It assesses the degree to which individuals are satisfied with their lives as a whole, reflecting a cognitive-judgmental component of subjective well-being. The scale has become a cornerstone instrument in well-being research, psychology, gerontology, and quality-of-life assessment across diverse populations.	The General Health Questionnaire-12 (GHQ-12) is a brief, 12-item self-report screening instrument for psychological distress and mental health problems in the general population. Developed by David P. Goldberg, the GHQ-12 is the most widely used short form of the longer General Health Questionnaire series. It is designed for rapid detection of minor psychiatric morbidity and assessment of psychological well-being in clinical, occupational health, and community settings.	The Hospital Anxiety and Depression Scale (HADS) is a 14-item self-report instrument measuring anxiety and depression symptoms in medically ill populations. Developed by Zigmond and Snaith in 1983, the HADS was specifically designed for hospital and general medical settings where somatic symptoms of medical illness may confound assessment. It remains the standard anxiety-depression measure in medical, oncology, and cardiac populations worldwide.